SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038375
Filing Date
2020-08-07
Accepted
2020-08-07 18:00:23
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q2 2020 CUE cue-10q_20200630.htm   iXBRL 10-Q 1988500
2 EX-31.1 cue-ex311_6.htm EX-31.1 15548
3 EX-31.2 cue-ex312_8.htm EX-31.2 15794
4 EX-32.1 cue-ex321_7.htm EX-32.1 10529
5 GRAPHIC g0edk3lljdlx000001.jpg GRAPHIC 24996
  Complete submission text file 0001564590-20-038375.txt   7232856

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cue-20200630.xsd EX-101.SCH 53969
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20200630_cal.xml EX-101.CAL 41593
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20200630_def.xml EX-101.DEF 194360
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20200630_lab.xml EX-101.LAB 419849
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20200630_pre.xml EX-101.PRE 333217
11 EXTRACTED XBRL INSTANCE DOCUMENT cue-10q_20200630_htm.xml XML 1185530
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 201085726
SIC: 2834 Pharmaceutical Preparations